HLA-DP genotyping in HLA-A,B, and DR identical intrafamilial bone marrow transplantation. 1990

R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
Laboratoire d'Histocompatibilité et d'Immunologie, Hôpital Saint-Louis, Paris, France.

In a study carried out for patients receiving intrafamilial HLA-A,B,DR identical, MLC negative bone marrow transplants, RFLP profiles of HLA-class II for 27 donor recipient pairs were analyzed. Twenty-four pairs were found HLA-class II identical while three pairs were HLA-DP incompatible. The patients of these three pairs did not reveal any acute GVHD greater than or equal to grade II. The seven cases of acute GVHD greater than or equal to grade II found in our panel were HLA-DR, DQ, and DP compatible. Thus, in practical terms pretransplantation HLA-DP typing does not seem necessary for intrafamilial HLA-identical, MLC negative BMT. On the other hand, this work confirmed that it is possible to type for HLA-DP using molecular biological techniques, and this in itself may have some important implications for unrelated BMT.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006682 HLA-DP Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-PL Antigens,HLA-SB Antigens,HLA-DP,HLA-PL,HLA-SB,Antigens, HLA-DP,Antigens, HLA-PL,Antigens, HLA-SB,HLA DP Antigens,HLA PL Antigens,HLA SB Antigens
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens

Related Publications

R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
November 1990, Bone marrow transplantation,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
June 1994, Bone marrow transplantation,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
February 1987, Transplantation proceedings,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
June 1994, Blood,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
January 1994, Blood,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
October 1991, Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
November 1990, Tissue antigens,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
April 1995, Bone marrow transplantation,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
November 1987, Tissue antigens,
R al-Daccak, and P Loiseau, and A Soulie, and F Varrin, and C Rabian, and C Raffoux, and D Cohen, and L Degos, and E Gluckman, and J Colombani
August 1995, Blood,
Copied contents to your clipboard!